JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, E. S.
Right arrow Articles by Blobel, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, E. S.
Right arrow Articles by Blobel, G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 272, Number 43, Issue of October 24, 1997 pp. 26799-26802
©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

COMMUNICATION:
Ubc9p Is the Conjugating Enzyme for the Ubiquitin-like Protein Smt3p*

(Received for publication, August 19, 1997, and in revised form, August 26, 1997)

Erica S. Johnson Dagger and Günter Blobel

From the Laboratory of Cell Biology, Howard Hughes Medical Institute, Rockefeller University, New York, New York 10021

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES


ABSTRACT

At least one essential function of Smt3p, a Saccharomyces cerevisiae ubiquitin-like protein similar to the mammalian protein SUMO-1, involves its posttranslational covalent attachment to other proteins. Using Smt3p affinity chromatography, we have isolated the second enzyme of the Smt3p conjugation pathway and have found that it is identical to Ubc9p, a previously identified protein that has extensive sequence similarity to the ubiquitin-conjugating enzymes (E2s) and that is required for yeast to progress through mitosis. A hallmark of E2s is the ability to form a thioester bond-containing covalent intermediate with ubiquitin (Ub). While we were unable to detect formation of a Ub~Ubc9p thioester, Ubc9p was found to form a thioester with Smt3p, indicating that Ubc9p is the functional analog of E2s in the Smt3p pathway and that this step is distinct from the ubiquitin pathway. Ubc9p is required for attachment of Smt3p to other proteins in vitro, suggesting that it is the only such enzyme in S. cerevisiae. These results suggest that, like ubiquitination, Smt3p conjugation may be a critical modification in cell cycle regulation.


INTRODUCTION

SMT3 is an essential Saccharomyces cerevisiae gene encoding a member of a family of ubiquitin-like proteins, including the mammalian protein SUMO-1 (1) (also called GMP1, PIC1, UBL1, or sentrin (2-5)). SUMO-1 was isolated as a protein covalently linked to the Ran-GTPase-activating protein (RanGAP1),1 and it is also conjugated to a number of other, primarily nuclear, proteins (1-3, 6). Smt3p, which is 48% identical to SUMO-1 and 17% identical to Ub, also becomes attached to several proteins posttranslationally, and at least one of its essential functions is mediated by its attachment to another protein (7).

Ubiquitin (Ub) conjugation is carried out by a multistep pathway culminating in formation of an isopeptide bond between the C-terminal carboxyl group of Ub and the epsilon -amino group of a lysine side chain in an acceptor protein (8, 9). In the initial step, Ub-activating enzyme (E1) utilizes ATP to adenylate the Ub C terminus, which is then transferred to a conserved Cys residue in the E1, yielding an E1~Ub thioester, AMP, and pyrophosphate. Ub is transferred from the E1 to a Cys residue in a Ub-conjugating enzyme (E2). Cells contain multiple E2s (13 in yeast by sequence similarity) which are involved in ubiquitinating different proteins. In some cases Ub can be transferred directly from the E2 to the acceptor protein, but more often Ub-isopeptide bond formation is facilitated by a third heterogeneous class of proteins termed Ub-protein ligases or recognins (E3).

Several features of the Ub pathway are conserved in the early steps of the Smt3p conjugation pathway (7). Like Ub, the SMT3 translation product is proteolytically processed to expose its mature C terminus. Smt3p undergoes ATP-dependent activation by a heterodimeric activating enzyme consisting of Uba2p, a 71-kDa protein with extensive sequence similarity to the C-terminal region of E1s, including the active site Cys residue participating in the thioester (10), and Aos1p, a 40-kDa protein similar to the N termini of E1s (7). While the Smt3p- and Ub-activating enzymes are related, they do not interact with each other's substrates, suggesting that the two pathways are distinct.

One candidate to be the Smt3p-conjugating enzyme is Ubc9p, a member of the E2 sequence family whose Xenopus leavis homolog co-immunoprecipitates with a complex including SUMO-1-conjugated RanGAP1 (11) and whose human homolog interacts in a two-hybrid screen with SUMO-1 (4). UBC9 is an essential gene. Conditional ubc9 mutants arrest in the cell cycle at G2/M and are impaired in proteolysis of both B-type cyclins (12) and G1 cyclins (13). However, Ubc9p does not seem to be the E2 involved in cyclin B ubiquitination (14, 15). While it has been suggested that Ubc9p functions as an E2 in the Ub pathway, there is no clear biochemical data to support this hypothesis.

We have found that Ubc9p is a Smt3p-conjugating enzyme and that it is likely to constitute the only Smt3p-conjugating activity in yeast. Furthermore, Ubc9p does not seem to be a Ub-conjugating enzyme, suggesting that the ubc9 cell cycle defect actually results from impairment of Smt3p conjugation.


EXPERIMENTAL PROCEDURES

Genetic Techniques and Strains

Standard techniques were used (16). S. cerevisiae strains used were DF5alpha (MATalpha trp1-1 ura3-52 his3-Delta 200 leu2-3,112 lys2-801) (17) and the DF5-derived strain YWO102 (MATalpha ubc9Delta ::TRP1 leu2::ubc9Pro-Ser::LEU2) (12), which was a generous gift of S. Jentsch (Heidelberg, Germany).

Plasmid Constructs and Recombinant Proteins

pET21b or pET11a (Novagen)-based Escherichia coli expression plasmids expressing N-terminally His6- (18) and FLAG-tagged (19) Smt3p (HF-Smt3p) and His6-tagged Aos1p and Uba2p have been described (7). pET21b-based plasmids for expressing Ubc9p-, Ubc2p-, and Pex4p-tagged C-terminally with His6 were produced by polymerase chain reaction. The Ubc2p construct expresses Ubc2p truncated after Met153, deleting most of the acidic C-terminal domain. A pET21b-based plasmid expressing N-terminally His6- and FLAG-tagged ubiquitin bearing Lys48 right-arrow Arg, Lys63 right-arrow Arg and Gly76 right-arrow Ala mutations (HF-Ub(A76)) was also produced by polymerase chain reaction. The A76 mutation alters the kinetics of thioester formation (20). Construction details are available on request. Proteins were expressed in E. coli and purified by Ni-NTA chromatography as described (7). The H-Uba2p·Aos1p complex was further purified by Smt3p affinity and gel filtration chromatography (7). Purified recombinant Ubc4p was a generous gift of V. Chau (Wayne State University School of Medicine, Detroit, MI). His6-tagged Uba1p was purified from yeast lysate of strain JD77-1A (MATa uba1Delta ::HIS3) (10) bearing plasmid pJD325, which expresses H-Uba1p from PCUP1, both gifts of J. Dohmen (Heinrich-Heine Universität, Düsseldorf, Germany). Uba1p was purified by Ni-NTA chromatography as described for Uba2p (7) followed by Ub affinity chromatography (21).

Smt3p Affinity Chromatography

Ni-NTA-purified recombinant Aos1p and Uba2p were applied to an HF-Smt3p-Affi-Gel 15 column and washed as described (7). A few milligrams of each protein bound. Yeast nuclear extract, consisting of the soluble fractions (primarily the load) below the nuclear envelopes in a Nycodenz/sucrose flotation gradient, prepared as described (22), was a generous gift of R. Beckmann and D. Peter. Extract containing ~20 mg of protein was dialyzed against 50 mM BisTris (pH 6.5), 50 mM NaCl, 1 mM MgCl2, and 1 mM beta -mercaptoethanol (beta -ME), brought to final concentrations 50 mM BisTris (pH 6.5), 75 mM NaCl, 5 mM MgCl2, 2 mM ATP, and 0.5 mM beta -ME and applied to the Aos1p/Uba2p-preloaded HF-Smt3p column. The column was washed with 10 column volumes of the same buffer except containing 1 M NaCl and eluted as described (7). The eluate was exchanged into 50 mM Tris (pH 8.0), 300 mM NaCl, 1 mM MgCl2, and 1 mM beta -ME using a Biomax-10 ultrafiltration unit (Millipore), bound to 0.5 ml of Ni-NTA-agarose, and washed with 5 column volumes of 50 mM sodium phosphate (pH 6.0), 300 mM NaCl, and 10% glycerol. The unbound and wash fractions were pooled and fractionated by SDS-PAGE on a 4-20% gradient gel (Novex) followed by Coomassie Blue staining. Bands were excised from the gel and identified by direct analysis of a Lys-C endoproteinase digest by MALDI-TOF mass spectrometry at the Rockefeller University Protein/DNA Technology Center as described (23). The six major peaks, with measured masses of 856.68, 1080.54, 1702.28, 1829.39, 2892.92, and 3463.25 Da, are within 1.6 mass units of the peptide masses predicted by a theoretical Lys-C digest of Ubc9p (using the ProFound and MS-Fit programs: http://chait-sgi.rockefeller.edu/cgi-bin/ProFoundandhttp://prospector.ucsf.edu/htmlucsf/msfit.htm), assuming the N terminus is acetylated and cysteine residues are modified by acrylamide.

Thioester Formation Assays

Thioester formation reactions contained 50 mM BisTris (pH 6.5), 100 mM NaCl, 10 mM MgCl2, 0.1 mM DTT and some of the following: 5 mM ATP, 30 µg/ml HF-Smt3p or HF-Ub(A98), 15 µg/ml Aos1p/Uba2p heterodimer or Uba1p, and ~15 µg/ml Ubc9p, Ubc4p, Pex4p, or Rad6p (Ubc4p and Pex4p contained noticeable amounts of contaminants). HF-Smt3p-containing reactions were incubated 30 min and HF-Ub(A76)-containing reactions 90 min at 25 °C and stopped by addition of SDS-containing loading buffer either lacking reducing agent or containing 100 mM DTT, followed by a 10-min incubation at 37 °C, SDS-PAGE (6-15% acrylamide gradient) and either Coomassie Blue staining or immunoblotting using the M2 anti-FLAG antibody (IBI/Kodak).

In Vitro Smt3p Conjugation

Whole yeast cell lysate from DF5alpha or YWO102 (both after 90-min incubation at 37 °C) were prepared as described (7) and exchanged into 50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM MgCl2, and 0.1 mM DTT using a Sephadex G-25 column. Reactions were incubated for 90 min at 25 °C and contained 25 mM Tris (pH 7.5), 75 mM NaCl, 10 mM MgCl2, 50 µM DTT, 10 mg/ml whole yeast lysate, 30 µg/ml HF-Smt3p and, where indicated, 5 mM ATP and/or 5 µg/ml Ubc9p.


RESULTS

Identification of the Smt3p-conjugating Enzyme

E1s and E2s can be readily purified by "covalent affinity chromatography" (21) by adding ATP to a protein mixture containing these enzymes and incubating with an affinity column to which Ub has been coupled. E1s and E2s form thioester bonds with the column-bound Ub and then can be gently eluted in buffer containing a thiol reducing agent, such as DTT, which breaks the thioester bonds.

We attempted an analogous approach to purifying the Smt3p-conjugating enzyme(s) using a column linked to His6 (18)- and FLAG-tagged (19) Smt3p (HF-Smt3p) (mature processed Smt3p having C-terminal Gly98 will be referred to as Smt3p). Because the Smt3p-conjugating enzyme would be predicted to bind the column by displacing Uba2p/Aos1p, which is necessary to activate the column-bound Smt3p, the Smt3p column was prebound with recombinant His6-tagged Uba2p and Aos1p to improve the efficiency of conjugating enzyme binding. Next, ATP-supplemented yeast nuclear extract was applied to the column, which was then washed and eluted with DTT. Nuclear extract was used because Uba2p has been reported to be nuclear (10) and because we had previously found a yeast cytosolic fraction to be inactive in Smt3p conjugation (data not shown). The eluate contained predominantly recombinant Uba2p and Aos1p (data not shown), but as these bore His6 tags, they were selectively removed by Ni-NTA chromatography. The resulting fraction contained four major bands of 90, 50, 40, and 19 kDa and a number of minor bands (Fig. 1). The 90- and 40-kDa bands are likely to represent the endogenous Uba2p and Aos1p from the yeast lysate. The other two bands were analyzed by direct mass spectrometric analysis of a protease digestion mixture (see "Experimental Procedures"). The 50-kDa band contained the elongation factor EF1alpha , and the 19-kDa band contained Ubc9p.


Fig. 1. Yeast proteins that bind an Smt3p affinity column. ATP-supplemented yeast nuclear extract was applied to an Smt3p column that had been prebound with recombinant Aos1p and Uba2p. The DTT eluate, after removal of recombinant proteins, is shown (see "Results" and "Experimental Procedures").

[View Larger Version of this Image (31K GIF file)]


The isolation of EF1alpha in this fractionation was intriguing, as EF1alpha has been connected to Ub-like systems before, as an isopeptidase involved in Ub-dependent proteolysis of N-alpha -acetylated substrates (24). However, it is also an extremely abundant protein and a frequent contaminant in affinity purifications.2 We attempted to purify EF1alpha and add it to some of the reactions described below, but did not obtain any conclusive results.

Ubc9p Thioester Formation

Smt3p-thioester formation assays were performed using purified, His6-tagged recombinant proteins expressed in E. coli. Incubation of the Uba2p/Aos1p heterodimer with ATP and HF-Smt3p promoted formation of the ~105-kDa HF-Smt3p~Uba2p thioester (7) (Fig. 2, lane 6). When purified Ubc9p was also added to this reaction, a different HF-Smt3p-containing band formed at ~38 kDa (Fig. 2, lanes 2 and 7). In addition to Ubc9p, formation of this product required ATP, Uba2p, and Aos1p. Furthermore, the vast majority of this product could be destroyed by incubation with DTT (Fig. 2, lanes 1-8). The data are consistent with the 38-kDa product being the HF-Smt3p~Ubc9p thioester. The DTT-sensitive bond cannot be a disulfide bond, as HF-Smt3p does not contain any cysteine residues. Coomassie Blue staining of the reaction products provided additional evidence that Ubc9p was the other component of the 38-kDa product, as the Ubc9p bands were significantly depleted upon ATP incubation and formation of the 38-kDa band and reappeared upon addition of DTT (Fig. 2, lanes 1-3; Ubc9p ran as a ~20-kDa doublet under nonreducing conditions). Also, formation of the 38-kDa product was entirely dependent on the presence of Uba2p/Aos1p, strengthening the analogy between this reaction and that of Ub, E1s, and E2s. This reaction also formed small amounts of a series of DTT-insensitive HF-Smt3p-containing bands, one of which ran at the same position as the HF-Smt3p~Ubc9p thioester. These bands could represent a polymer of HF-Smt3p or isopeptide-containing conjugates of Smt3p to Ubc9p.


Fig. 2. Ubc9p forms a thioester with Smt3p. Purified recombinant HF-Smt3p was incubated for 30 min at 25 °C with 5 mM ATP (lanes 2, 3, and 5-8), purified recombinant Aos1p/Uba2p heterodimer (lanes 1-4 and 6-8), and purified recombinant Ubc9p (lanes 1-5 and 7-8). Reactions were then incubated with SDS-loading buffer lacking reducing agent (lanes 1, 2, and 4-7) or containing 100 mM DTT (lanes 3 and 8) at 37 °C for 10 min, followed by SDS-PAGE and either Coomassie Blue staining (lanes 1-3) or immunoblotting using the monoclonal antibody against the FLAG epitope (lanes 4-8). Presence or absence of various components is indicated above the lanes. The bands corresponding to free HF-Smt3p, Ubc9p, Aos1p, and Uba2p are indicated. Ubc9p runs as a doublet under nondenaturing conditions. An arrow designates the putative HF-Smt3p~Ubc9p thioester product and an arrowhead the HF-Smt3p~Uba2p thioester. Note reduced level of Ubc9p in lane 2 relative to lanes 1 and 3.

[View Larger Version of this Image (37K GIF file)]


We also asked whether Ubc9p was capable of forming thioesters with Ub as well as with Smt3p. When the yeast E2s Ubc4p, Pex4p (Pas2p/Ubc10p), or Rad6p (Ubc2p), which are involved in bulk proteolysis (25), peroxisome biogenesis (26), and DNA repair (27), respectively, were mixed with Uba1p (the yeast E1) and His6- and FLAG-tagged Ub(A76) (see "Experimental Procedures"), addition of ATP caused these E2s to shift almost quantitatively into higher molecular weight forms (Fig. 3, lanes 1-6). These products were DTT-sensitive and contained HF-Ub(A76) (data not shown), suggesting that they were the corresponding Ub-E2 thioesters. No thioester product between Ubc9p and Ub could be detected under these conditions either by Coomassie staining (Fig. 3, lane 8) or by immunoblotting with the antibody against the FLAG epitope (Fig. 3, lane 9). Conversely, extremely little or no thioester product was detected between Smt3p and either Ubc4p, Pex4p, or Rad6p (data not shown), demonstrating that the transthiolation reaction is very specific.


Fig. 3. Thioester formation with ubiquitin. Purified recombinant HF-Ub(A76) and purified Uba1p were incubated for 90 min at 25 °C with 5 mM ATP (lanes 2, 4, 6, 8, and 9) and partially purified recombinant Ubc4p (lanes 1 and 2), Pex4p (lanes 3 and 4), Rad6p (lanes 5 and 6), or Ubc9p (lanes 7-9). Reactions were then incubated with SDS-loading buffer lacking reducing agent at 37 °C for 10 min, followed by SDS-PAGE and Coomassie Blue staining (lanes 1-8). Lane 9, same as lane 8, except detected by immunoblotting with the anti-FLAG antibody. Presence or absence of various components is indicated above the lanes. The bands corresponding to free HF-Ub(A76), Ubc4p, Pex4p, Rad6p, Ubc9p, and Uba1p are indicated. Ubc9p runs as a doublet and Pex4p as several bands under nonreducing conditions. An asterisk indicates the Ub-Uba1p thioester. A square bracket designates the putative HF-Ub(A76)~E2 thioester products. A square indicates a disulfide-linked dimer of Ubc9p.

[View Larger Version of this Image (41K GIF file)]


Ubc9p Is Essential for Smt3p Conjugation

When HF-Smt3p and ATP were incubated with whole yeast cell lysate from wild-type cells, a series of DTT-resistant high molecular weight HF-Smt3p-containing bands formed (7) (Fig. 4, lane 2). The pattern of Smt3p-containing bands was similar but not identical to that seen in vivo, with a greater proportion of HF-Smt3p found in very high molecular mass bands >200 kDa (7). The ubc9-1 mutant, which has a Ser residue in place of Pro69, is temperature-sensitive by virtue of the fact that Ubc9(P69S)p is rapidly degraded at 37 °C (28). When yeast lysate made from this mutant strain after incubation at 37 °C was used in the same reaction, no Smt3p conjugation was detected even on long exposure. (Fig. 4, lane 3). Addition of recombinant Ubc9p restored the Smt3p conjugation activity (Fig. 4, lane 4). These results suggest a direct requirement for Ubc9p in HF-Smt3p conjugation to other proteins in these lysates. Thus, Ubc9p is likely to be the only Smt3p-conjugating enzyme in yeast, at least that is expressed under normal growth conditions.


Fig. 4. Ubc9p is required for Smt3p conjugation to other proteins in vitro. HF-Smt3p and whole yeast cell lysate from DF5alpha (UBC9) (lanes 1 and 2) or YWO102 (ubc9-1) were incubated for 90 min at 25 °C with 5 mM ATP (lanes 2-4) and purified Ubc9p (lane 4), as indicated. Samples were heated at 100 °C in beta -mercaptoethanol-containing SDS-sample buffer, followed by SDS-PAGE and immunoblotting using the anti-FLAG antibody. The band corresponding to HF-Smt3p is indicated. A half-open square bracket designates high molecular weight HF-Smt3p conjugates. wt, wild-type.

[View Larger Version of this Image (52K GIF file)]



DISCUSSION

Our results show that the Smt3p conjugation pathway is distinct from the Ub pathway, at least up to formation of the thioester with the conjugating enzymes. However, sequence comparisons of of the Smt3p-conjugating enzyme Ubc9p to the Ub-conjugating enzymes Rad6p (Ubc2p), Ubc4p, and Pex4p (Pas2p/Ubc10p) do not reveal any large continuous regions of dissimilarity, and the degree of sequence similarity between Ubc9p and any of these three E2s is comparable with that among the E2s. Ubc4p is 37% identical to Ubc2p, 35% identical to Pex4p, and 34% identical to Ubc9p. Yet the transthiolation reaction involving Aos1p/Uba2p and Smt3p is extremely selective for Ubc9p, and the reaction involving Uba1p and Ub selects strongly against Ubc9p. One possible factor in this discrimination may be that Ubc9p is much more basic than the other proteins, with a pI of 9.2 as compared with 6.3 for Ubc4p, 5.4 for Pex4p, or 4.0 for Rad6p. How this specificity is generated depends on whether conjugating enzymes interact directly with the activating enzyme, the Ub-like protein, or both.

Although our inability to detect Ub~Ubc9p thioesters does not prove that Ubc9p never participates in Ub conjugation in vivo, it is unlikely that the metabolic stabilization of cyclins observed in ubc9 mutants (12, 13) results directly from reduced ubiquitination of these proteins by Ubc9p, both because of our results and because the E2s that participate in cyclin B ubiquitination have been isolated and do not include Ubc9p (14, 15). It is also very unlikely that Smt3p conjugation substitutes for ubiquitination in targeting cyclins for proteolysis, as cyclins have been heavily studied and never found to be Smt3p-conjugated. Furthermore, Smt3p, which is only 17% identical to Ub, probably does not target its substrates for proteasome-dependent proteolysis. Smt3p conjugation could affect cyclin proteolysis by activating some component of the ubiquitination/proteolysis machinery, or its effect could be several steps removed from ubiquitination. It also has not been excluded that Ubc9p could be required for the conjugation of a different Ub-like protein, which could mediate the cell cycle effect. Smt3p, Aos1p, and Uba2p are all essential genes (7, 10), which is consistent with their being required for cells to transit mitosis, but the arrest phenotypes of conditional alleles of these genes have not been characterized. Ubc9p, Smt3p, and SUMO-1 interact genetically or in the two-hybrid system with a variety of DNA-binding proteins, including centromere-binding proteins (29, 30), proteins involved in recombination (4, 31) and transcription factors (4, 32-34), any of which might affect cell cycle progression. Identification of the targets of Smt3p conjugation should address these questions.


FOOTNOTES

*   This work was supported by the Howard Hughes Medical Institute (to G. B.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Dagger    Postdoctoral fellow of the American Cancer Society (PF-4114). To whom correspondence should be addressed: Rockefeller University, Box 168, 1230 York Ave., New York, NY 10021. Tel.: 212-327-8181; Fax: 212-327-7880; E-mail: johnsoe{at}rockvax.rockefeller.edu.
1   The abbreviations used are: RanGAP1, Ran-GTPase-activating protein; Ub, ubiquitin; E1, ubiquitin-activating enzyme; E2, ubiquitin-conjugating enzyme; E3, ubiquitin-protein ligase; HF-Smt3p, His6- and FLAG-epitope-tagged mature Smt3p; DTT, dithiothreitol; NTA, nitrilotriacetic acid; EF1alpha , elongation factor 1alpha ; PAGE, polyacrylamide gel electrophoresis; MALDI-TOF, matrix-assisted laser desorption/ionization time of flight; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)propane-1,3-diol.
2   R. Beckmann, personal communication.

ACKNOWLEDGEMENTS

We thank R. Beckmann and D. Peter for the yeast nuclear extract, S. Jentsch, V. Chau, and J. Dohmen for strains, plasmids, and other reagents and members of the Rockefeller University Protein/DNA Technology Center for DNA sequencing and especially F. Gharahdaghi for MALDI-TOF analysis. We also thank M. Matunis and J. Rosenblum for critical reading of the manuscript.


REFERENCES

  1. Mahajan, R., Delphin, C., Guan, T., Gerace, L., and Melchior, F. (1997) Cell 88, 97-107 [CrossRef][Medline] [Order article via Infotrieve]
  2. Matunis, M. J., Coutavas, E., and Blobel, G. (1996) J. Cell Biol. 135, 1457-1470 [Abstract/Free Full Text]
  3. Boddy, M. N., Howe, K., Etkin, L. D., Solomon, E., and Freemont, P. S. (1996) Oncogene 13, 971-982 [Medline] [Order article via Infotrieve]
  4. Shen, Z., Pardington-Purtymun, P. E., Comeaux, J. C., Moyzis, R. K., and Chen, D. J. (1996) Genomics 37, 183-186 [CrossRef][Medline] [Order article via Infotrieve]
  5. Okura, T., Gong, L., Kamitani, T., Wada, T., Okura, I., Wei, C. F., Chang, H. M., and Yeh, E. T. (1996) J. Immunol. 157, 4277-4281 [Abstract]
  6. Kamitani, T., Nguyen, H. P., and Yeh, E. T. H. (1997) J. Biol. Chem. 272, 14001-14004 [Abstract/Free Full Text]
  7. Johnson, E. S., Schwienhorst, I., Dohmen, R. J., and Blobel, G. (1997) EMBO J. 16, 5509-5519 [CrossRef][Medline] [Order article via Infotrieve]
  8. Pickart, C. M. (1988) in Ubiquitin (Rechsteiner, M., ed), pp. 77-99, Plenum Press, New York
  9. Hochstrasser, M. (1996) Annu. Rev. Genet. 30, 405-439 [CrossRef][Medline] [Order article via Infotrieve]
  10. Dohmen, R. J., Stappen, R., McGrath, J. P., Forrová, H., Kolarov, J., Goffeau, A., and Varshavsky, A. (1995) J. Biol. Chem. 270, 18099-18109 [Abstract/Free Full Text]
  11. Saitoh, H., Pu, R., Cavenagh, M., and Dasso, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3736-3741 [Abstract/Free Full Text]
  12. Seufert, W., Futcher, B., and Jentsch, S. (1995) Nature 373, 78-81 [CrossRef][Medline] [Order article via Infotrieve]
  13. Blondel, M., and Mann, C. (1996) Nature 384, 279-282 [CrossRef][Medline] [Order article via Infotrieve]
  14. Yu, H., King, R. W., Peters, J. M., and Kirschner, M. W. (1996) Curr. Biol. 6, 455-466 [CrossRef][Medline] [Order article via Infotrieve]
  15. Aristarkhov, A., Eytan, E., Moghe, A., Admon, A., Hershko, A., and Ruderman, J. V. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 4294-4299 [Abstract/Free Full Text]
  16. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Smith, J. A., Seidman, J. G., and Struhl, K. (1994) Current Protocols in Molecular Biology, Wiley-Interscience, New York
  17. Finley, D., Özkaynak, E., and Varshavsky, A. (1987) Cell 48, 1035-1046 [CrossRef][Medline] [Order article via Infotrieve]
  18. Hoffman, A., and Roeder, R. G. (1991) Nucleic Acids Res. 19, 6337-6338 [Free Full Text]
  19. Brizzard, B. L., Chubet, R. G., and Vizard, D. L. (1994) BioTechniques 16, 730-734 [Medline] [Order article via Infotrieve]
  20. Pickart, C. M., Kasperek, E. M., Beal, R., and Kim, A. (1994) J. Biol. Chem. 269, 7115-7123 [Abstract/Free Full Text]
  21. Ciechanover, A., Elias, S., Heller, H., and Hershko, A. (1982) J. Biol. Chem. 257, 2537-2542 [Abstract/Free Full Text]
  22. Strambio-de-Castillia, C., Blobel, G., and Rout, M. P. (1995) J. Cell Biol. 131, 19-31 [Abstract/Free Full Text]
  23. Gharahdaghi, F., Kirchner, M., Fernandez, J., and Mische, S. M. (1996) Anal. Biochem. 233, 94-99 [CrossRef][Medline] [Order article via Infotrieve]
  24. Gonen, H., Dickman, D., Schwartz, A. L., and Ciechanover, A. (1996) Adv. Exp. Med. Biol. 389, 209-219 [Medline] [Order article via Infotrieve]
  25. Seufert, W., and Jentsch, S. (1990) EMBO J. 9, 543-550 [Medline] [Order article via Infotrieve]
  26. Wiebel, F. F., and Kunau, W. H. (1992) Nature 359, 73-76 [CrossRef][Medline] [Order article via Infotrieve]
  27. Jentsch, S., McGrath, J. P., and Varshavsky, A. (1987) Nature 329, 131-134 [CrossRef][Medline] [Order article via Infotrieve]
  28. Betting, J., and Seufert, W. (1996) J. Biol. Chem. 271, 25790-25796 [Abstract/Free Full Text]
  29. Meluh, P. B., and Koshland, D. (1995) Mol. Biol. Cell 6, 793-807 [Abstract]
  30. Jiang, W., and Koltin, Y (1996) Mol. Gen. Genet. 251, 153-160 [Medline] [Order article via Infotrieve]
  31. Kovalenko, O. V., Plug, A. W., Haaf, T., Gonda, D. K., Ashley, T., Ward, D. C., Radding, C. M., and Golub, E. I. (1996) Proc. Natl Acad. Sci. U. S. A. 93, 2958-2963 [Abstract/Free Full Text]
  32. Hateboer, G., Hijmans, E. M., Nooij, J. B., Schlenker, S., Jentsch, S., and Bernards, R. (1996) J. Biol. Chem. 271, 25906-25911 [Abstract/Free Full Text]
  33. Gottlicher, M., Heck, S., Doucas, V., Wade, E., Kullmann, M., Cato, A. C., Evans, R. M., and Herrlich, P. (1996) Steroids 61, 257-262 [CrossRef][Medline] [Order article via Infotrieve]
  34. Kho, C. J., Huggins, G. S., Endege, W. O., Hsieh, C. M., Lee, M. E., and Haber, E. (1997) J. Biol. Chem. 272, 3845-3851 [Abstract/Free Full Text]

©1997 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Cell Biol.Home page
Y.-Q. Zhang and K. D. Sarge
Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies
J. Cell Biol., July 7, 2008; (2008) jcb.200712124.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
Y. Wang, I. Ladunga, A. R. Miller, K. M. Horken, T. Plucinak, D. P. Weeks, and C. P. Bailey
The Small Ubiquitin-Like Modifier (SUMO) and SUMO-Conjugating System of Chlamydomonas reinhardtii
Genetics, May 1, 2008; 179(1): 177 - 192.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, M. L. Goodson, Y. Hong, and K. D. Sarge
MEL-18 Interacts with HSF2 and the SUMO E2 UBC9 to Inhibit HSF2 Sumoylation
J. Biol. Chem., March 21, 2008; 283(12): 7464 - 7469.
[Abstract] [Full Text] [PDF]


Home page
Protein Sci.Home page
S. Lorenzen and Y. Zhang
Monte Carlo refinement of rigid-body protein docking structures with backbone displacement and side-chain optimization
Protein Sci., December 1, 2007; 16(12): 2716 - 2725.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Geletu, M. Y. Balkhi, A. A. Peer Zada, M. Christopeit, J. A. Pulikkan, A. K. Trivedi, D. G. Tenen, and G. Behre
Target proteins of C/EBP{alpha}p30 in AML: C/EBP{alpha}p30 enhances sumoylation of C/EBP{alpha}p42 via up-regulation of Ubc9
Blood, November 1, 2007; 110(9): 3301 - 3309.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Jakobs, F. Himstedt, M. Funk, B. Korn, M. Gaestel, and R. Niedenthal
Ubc9 fusion-directed SUMOylation identifies constitutive and inducible SUMOylation
Nucleic Acids Res., September 27, 2007; 35(17): e109 - e109.
[Abstract] [Full Text] [PDF]


Home page
Plant Physiol.Home page
S. A. Saracco, M. J. Miller, J. Kurepa, and R. D. Vierstra
Genetic Analysis of SUMOylation in Arabidopsis: Conjugation of SUMO1 and SUMO2 to Nuclear Proteins Is Essential
Plant Physiology, September 1, 2007; 145(1): 119 - 134.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Williams, M. van den Berg, R. R. Sprenger, and B. Distel
A Conserved Cysteine Is Essential for Pex4p-dependent Ubiquitination of the Peroxisomal Import Receptor Pex5p
J. Biol. Chem., August 3, 2007; 282(31): 22534 - 22543.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. F. Woeller, D. D. Anderson, D. M. E. Szebenyi, and P. J. Stover
Evidence for Small Ubiquitin-like Modifier-dependent Nuclear Import of the Thymidylate Biosynthesis Pathway
J. Biol. Chem., June 15, 2007; 282(24): 17623 - 17631.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
P.-J. Hamard, M. Boyer-Guittaut, B. Camuzeaux, D. Dujardin, C. Hauss, T. Oelgeschlager, M. Vigneron, C. Kedinger, and B. Chatton
Sumoylation delays the ATF7 transcription factor subcellular localization and inhibits its transcriptional activity
Nucleic Acids Res., February 28, 2007; 35(4): 1134 - 1144.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
R.-Y. Huang, D. Kowalski, H. Minderman, N. Gandhi, and E. S. Johnson
Small Ubiquitin-Related Modifier Pathway Is a Major Determinant of Doxorubicin Cytotoxicity in Saccharomyces cerevisiae
Cancer Res., January 15, 2007; 67(2): 765 - 772.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
M. Nowak and M. Hammerschmidt
Ubc9 Regulates Mitosis and Cell Survival during Zebrafish Development
Mol. Biol. Cell, December 1, 2006; 17(12): 5324 - 5336.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Tomoiu, A. Gravel, R. M. Tanguay, and L. Flamand
Functional Interaction between Human Herpesvirus 6 Immediate-Early 2 Protein and Ubiquitin-Conjugating Enzyme 9 in the Absence of Sumoylation.
J. Virol., October 1, 2006; 80(20): 10218 - 10228.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Dorval and P. E. Fraser
Small Ubiquitin-like Modifier (SUMO) Modification of Natively Unfolded Proteins Tau and {alpha}-Synuclein
J. Biol. Chem., April 14, 2006; 281(15): 9919 - 9924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Klenk, J. Humrich, U. Quitterer, and M. J. Lohse
SUMO-1 Controls the Protein Stability and the Biological Function of Phosducin
J. Biol. Chem., March 31, 2006; 281(13): 8357 - 8364.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Yang, C.-T. Hsu, C.-Y. Ting, L. F. Liu, and J. Hwang
Assembly of a Polymeric Chain of SUMO1 on Human Topoisomerase I in Vitro
J. Biol. Chem., March 24, 2006; 281(12): 8264 - 8274.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
Z. Wang, G. M. Jones, and G. Prelich
Genetic Analysis Connects SLX5 and SLX8 to the SUMO Pathway in Saccharomyces cerevisiae
Genetics, March 1, 2006; 172(3): 1499 - 1509.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
Y. Takahashi, V. Yong-Gonzalez, Y. Kikuchi, and A. Strunnikov
SIZ1/SIZ2 Control of Chromosome Transmission Fidelity Is Mediated by the Sumoylation of Topoisomerase II
Genetics, February 1, 2006; 172(2): 783 - 794.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Wang and H. G. Dohlman
Pheromone-regulated Sumoylation of Transcription Factors That Mediate the Invasive to Mating Developmental Switch in Yeast
J. Biol. Chem., January 27, 2006; 281(4): 1964 - 1969.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Sentis, M. Le Romancer, C. Bianchin, M.-C. Rostan, and L. Corbo
Sumoylation of the Estrogen Receptor {alpha} Hinge Region Regulates Its Transcriptional Activity
Mol. Endocrinol., November 1, 2005; 19(11): 2671 - 2684.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takahashi and Y. Kikuchi
Yeast PIAS-type Ull1/Siz1 Is Composed of SUMO Ligase and Regulatory Domains
J. Biol. Chem., October 28, 2005; 280(43): 35822 - 35828.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
C. Denison, A. D. Rudner, S. A. Gerber, C. E. Bakalarski, D. Moazed, and S. P. Gygi
A Proteomic Strategy for Gaining Insights into Protein Sumoylation in Yeast
Mol. Cell. Proteomics, March 1, 2005; 4(3): 246 - 254.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
E. R. Leight, D. Glossip, and K. Kornfeld
Sumoylation of LIN-1 promotes transcriptional repression and inhibition of vulval cell fates
Development, March 1, 2005; 132(5): 1047 - 1056.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. ProteomicsHome page
D. D. Wykoff and E. K. O'Shea
Identification of Sumoylated Proteins by Systematic Immunoprecipitation of the Budding Yeast Proteome
Mol. Cell. Proteomics, January 1, 2005; 4(1): 73 - 83.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. A. Wohlschlegel, E. S. Johnson, S. I. Reed, and J. R. Yates III
Global Analysis of Protein Sumoylation in Saccharomyces cerevisiae
J. Biol. Chem., October 29, 2004; 279(44): 45662 - 45668.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. G. Panse, U. Hardeland, T. Werner, B. Kuster, and E. Hurt
A Proteome-wide Approach Identifies Sumoylated Substrate Proteins in Yeast
J. Biol. Chem., October 1, 2004; 279(40): 41346 - 41351.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L.-K. Chang, Y.-H. Lee, T.-S. Cheng, Y.-R. Hong, P.-J. Lu, J. J. Wang, W.-H. Wang, C.-W. Kuo, S. S.-L. Li, and S.-T. Liu
Post-translational Modification of Rta of Epstein-Barr Virus by SUMO-1
J. Biol. Chem., September 10, 2004; 279(37): 38803 - 38812.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
O. Staub
Ubiquitylation and Isgylation: Overlapping Enzymatic Cascades Do the Job
Sci. Signal., August 10, 2004; 2004(245): pe43 - pe43.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. O. Vertegaal, S. C. Ogg, E. Jaffray, M. S. Rodriguez, R. T. Hay, J. S. Andersen, M. Mann, and A. I. Lamond
A Proteomic Study of SUMO-2 Target Proteins
J. Biol. Chem., August 6, 2004; 279(32): 33791 - 33798.
[Abstract] [Full Text] [PDF]